Risk factors for severe and critically ill COVID‐19 patients: a review

Y Gao, M Ding, X Dong, J Zhang, A Kursat Azkur… - Allergy, 2021 - Wiley Online Library
The pandemic of coronavirus disease 2019 (COVID‐19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused an unprecedented global …

[HTML][HTML] COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis

FV Gerayeli, S Milne, C Cheung, X Li, CWT Yang… - …, 2021 - thelancet.com
Background Patients with chronic obstructive pulmonary disease (COPD) are highly
susceptible from respiratory exacerbations from viral respiratory tract infections. However, it …

[HTML][HTML] SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas

JA Müller, R Groß, C Conzelmann, J Krüger… - Nature …, 2021 - nature.com
Infection-related diabetes can arise as a result of virus-associated β-cell destruction. Clinical
data suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID‐19

D Munblit, P Bobkova, E Spiridonova… - Clinical & …, 2021 - Wiley Online Library
Background The long‐term sequalae of COVID‐19 remain poorly characterized. We
assessed persistent symptoms in previously hospitalized patients with COVID‐19 and …

Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD science committee report on COVID-19 and …

DMG Halpin, GJ Criner, A Papi, D Singh… - American journal of …, 2021 - atsjournals.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has raised
many questions about the management of patients with chronic obstructive pulmonary …

[HTML][HTML] Pathogenesis of multiple organ injury in COVID-19 and potential therapeutic strategies

M Lopes-Pacheco, PL Silva, FF Cruz… - Frontiers in …, 2021 - frontiersin.org
Severe acute respiratory disease coronavirus 2 (SARS-CoV-2, formerly 2019-nCoV) is a
novel coronavirus that has rapidly disseminated worldwide, causing the coronavirus disease …

[HTML][HTML] The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease

D Adeloye, O Elneima, L Daines… - The Lancet …, 2021 - thelancet.com
Persistent ill health after acute COVID-19—referred to as long COVID, the post-acute COVID-
19 syndrome, or the post-COVID-19 condition—has emerged as a major concern. We …

[HTML][HTML] Impact of comorbidity burden on mortality in patients with COVID-19 using the Korean health insurance database

SI Cho, S Yoon, HJ Lee - Scientific reports, 2021 - nature.com
We aimed to investigate the impact of comorbidity burden on mortality in patients with
coronavirus disease (COVID-19). We analyzed the COVID-19 data from the nationwide …

[HTML][HTML] Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study

G Beltramo, J Cottenet, AS Mariet… - European …, 2021 - Eur Respiratory Soc
Background Influenza epidemics were initially considered to be a suitable model for the
COVID-19 epidemic, but there is a lack of data concerning patients with chronic respiratory …

Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: systematic review and meta-analysis

AP Sunjaya, SM Allida, GL Di Tanna… - Journal of Asthma, 2022 - Taylor & Francis
Objective As COVID-19 spreads across the world, there are concerns that people with
asthma are at a higher risk of acquiring the disease, or of poorer outcomes. This systematic …